We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma (R2-CHOP2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01393756
Recruitment Status : Completed
First Posted : July 13, 2011
Last Update Posted : February 17, 2016
Centre Henri Becquerel
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2013
  Study Completion Date : November 2015